Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
89.38
-2.41 (-2.63%)
Aug 14, 2025, 1:51 PM - Market open
Glaukos Market Cap
Glaukos has a market cap or net worth of $5.12 billion as of August 14, 2025. Its market cap has decreased by -15.01% in one year.
Market Cap
5.12B
Enterprise Value
5.09B
1-Year Change
-15.01%
Ranking
Category
Stock Price
$89.38
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $5.12B, an increase of 412.55%. That is a compound annual growth rate of 17.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 5.26B | -36.33% |
| Dec 31, 2024 | 8.27B | 113.12% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 572.29B |
| Johnson & Johnson | 415.34B |
| AbbVie | 350.08B |
| UnitedHealth Group | 235.45B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 227.06B |
| Novo Nordisk | 222.88B |